Clinical Guides
Polycystic Ovary Syndrome: Lifelong, Metabolic and Fertility Care
An India-contextualised educational guide to polycystic ovary syndrome that supports shared decisions and safe referral; it is not an individual diagnosis, prescription or fertility-treatment plan.
MedNext Academy | 13 min read
Polycystic Ovary Syndrome: Lifelong, Metabolic and Fertility Care
An India-contextualised educational guide to polycystic ovary syndrome that supports shared decisions and safe referral; it is not an individual diagnosis, prescription or fertility-treatment plan.
Summary
Polycystic ovary syndrome (PCOS) is a common, heterogeneous endocrine condition with reproductive, metabolic, dermatological and psychological consequences. It is not synonymous with ovarian cysts, obesity, infertility or a single laboratory result. In adults, the 2023 International Evidence-based Guideline uses two of three features after exclusion of important mimics: clinical or biochemical hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology on ultrasound or anti-Mullerian hormone (AMH) as an alternative adult marker. Where irregular cycles and hyperandrogenism are both present, ultrasound or AMH is not required for diagnosis. Adolescents need a stricter approach: menstrual irregularity and hyperandrogenism are both needed, while ultrasound and AMH should not be used diagnostically because normal pubertal development overlaps with PCOS.
Care starts by naming the person’s priority: predictable bleeding and endometrial protection, hirsutism or acne, metabolic health, emotional wellbeing, contraception, or pregnancy. A positive diagnosis can reduce repeated testing and delay, but must not close differential diagnosis. Treatment is long-term and changes with reproductive plans. Lifestyle support is recommended for all, irrespective of body size; it is not a moral test or a prerequisite for respectful care.
PCOS confers increased risk of impaired glucose tolerance and type 2 diabetes regardless of BMI, as well as increased cardiovascular risk factors, obstructive sleep apnoea symptoms, depression and anxiety. Chronic anovulation can leave the endometrium unprotected. A coordinated plan therefore includes cycle history, pregnancy intention, cardiometabolic screening and explicit safety-netting, rather than chasing an ultrasound appearance alone.
How Common Is It?
PCOS is common, but a single prevalence figure is misleading because estimates vary by diagnostic criteria, age, setting and whether people with mild symptoms are counted. The important clinical point is that it is encountered across primary care, dermatology, gynaecology, endocrinology and infertility services. It can present soon after menarche, after stopping hormonal contraception, during evaluation of hirsutism or acne, while trying to conceive, or when dysglycaemia is found. Many people experience delayed recognition because symptoms are normalised or each manifestation is managed in isolation.
PCOS is a syndrome, not a static ovarian scan. Some people are lean, have regular-appearing cycles but intermittent anovulation, or have minimal visible hair growth. Others have marked metabolic risk without striking biochemical androgen elevation. Ethnicity, family history, weight trajectory, access to testing and contraceptive use can alter presentation and interpretation. Do not infer severity, adherence or reproductive potential from appearance.
For India, no national prevalence should be claimed from small urban, student or clinic-based samples. Diet, shift work, barriers to activity, cost of tests, stigma around infertility and access to specialist care all affect care pathways. The value of an early diagnosis is practical: it permits prevention of excess weight gain, screening for diabetes, appropriate menstrual protection, preconception preparation and treatment of symptoms that impair quality of life. It does not mean that every person needs medication or that pregnancy is impossible.
Risk Factors
PCOS has familial and developmental contributions, but there is no single causative test. A family history of PCOS, type 2 diabetes, hirsutism, irregular cycles or premature male-pattern hair loss may support suspicion but cannot establish diagnosis. Insulin resistance, higher weight, rapid weight gain, sleep disturbance and some medicines may worsen manifestations or metabolic risk; none should be used to blame the person for the condition. Weight stigma itself can deter care, so ask permission before weighing and explain why a measurement may inform risk assessment.
Risk assessment should distinguish risk of PCOS from risk arising within PCOS. Record menstrual frequency and duration, hirsutism progression, acne, scalp hair loss, fertility goals, pregnancy history, contraception, medicines and supplements. Ask about gestational diabetes, hypertension, dyslipidaemia, diabetes in first-degree relatives, smoking, blood-pressure history and symptoms of sleep apnoea such as snoring with unrefreshing sleep or daytime sleepiness. Screen sensitively for depression, anxiety, body-image distress, eating disorder symptoms and intimate-partner or family pressure around fertility.
Rapid-onset or severe virilisation, deepening voice, clitoromegaly, rapidly progressive alopecia, a palpable mass, Cushingoid features, galactorrhoea, severe headache or visual symptoms are not routine PCOS features and need prompt evaluation for another cause. Amenorrhoea without adequate progestogen exposure requires attention to pregnancy exclusion and endometrial protection; it must not be dismissed as an expected PCOS pattern.
Diagnosis
History
Establish menarche, cycle pattern, bleeding burden, duration of amenorrhoea, pregnancy possibility, contraceptive use and recent hormonal treatment. Record clinical hyperandrogenism, timing and rate of hair growth, acne or scalp hair loss, fertility duration and coital or partner factors. Ask about weight trajectory, medicines including valproate and exogenous androgens, supplements, diabetes symptoms, sleep symptoms and mental health. In adolescents, interpret cycle irregularity by years after menarche rather than applying adult cycle assumptions.
Examination
Measure blood pressure and assess weight-related measures only with consent. Document hirsutism distribution, acne, androgenic alopecia, acanthosis nigricans and signs that suggest an alternative diagnosis. Examine for Cushingoid appearance, thyroid disease, galactorrhoea, pelvic mass or rapid virilisation when indicated. A normal examination does not exclude PCOS, and a high BMI does not prove it.
Investigations
Exclude pregnancy where relevant and investigate mimics according to presentation, commonly thyroid dysfunction, hyperprolactinaemia, non-classic congenital adrenal hyperplasia and androgen-secreting tumour; assess for Cushing syndrome when features suggest it. The guideline prefers total and free testosterone assessment, ideally with validated high-quality assays, while recognising laboratory availability. Do not use an insulin concentration or insulin-resistance index as a routine diagnostic test. In adults, AMH can be used instead of ultrasound for polycystic ovarian morphology, not in addition to it; neither test is needed when irregular cycles and hyperandrogenism already establish the adult diagnosis. Obtain glycaemic assessment at diagnosis. The 75-g oral glucose tolerance test is the most accurate recommended test regardless of BMI; fasting glucose or HbA1c are alternatives when an OGTT cannot be done but are less accurate.
Differential Diagnosis
PCOS is a diagnosis made after excluding disorders that change treatment and urgency. Pregnancy, thyroid disease and hyperprolactinaemia can alter cycles. Non-classic congenital adrenal hyperplasia, Cushing syndrome, severe insulin resistance syndromes, acromegaly and exogenous androgen exposure can produce hyperandrogenic or menstrual symptoms. Markedly elevated androgens, sudden virilisation or rapid symptom progression raise concern for an ovarian or adrenal androgen-secreting tumour and require urgent specialist assessment rather than repeated cosmetic treatment.
Functional hypothalamic amenorrhoea may occur with low energy availability, excessive exercise, chronic illness or psychological stress and can coexist with body-size assumptions that obscure it. Primary ovarian insufficiency, pituitary disease, structural uterine pathology and medication effects also need consideration. Acne or idiopathic hirsutism may occur without ovulatory dysfunction, and a polycystic ovarian appearance can occur without PCOS.
Fertility assessment should not assume that anovulation is the only factor. Consider partner semen factors, tubal disease, age-related oocyte factors, endometriosis and coital or sexual difficulties. During pregnancy planning, evaluate diabetes, blood pressure, medicines and other comorbidities. A diagnosis of PCOS does not exempt a person from routine cervical screening, contraception counselling, investigation of abnormal bleeding or evidence-based assessment for other causes of pelvic pain.
Management
Use shared decision-making and agree the immediate goal. Lifestyle intervention, including healthy eating, physical activity and behavioural support, is core care for all people with PCOS. The 2023 guideline does not identify one diet or exercise type as superior; choose an affordable, culturally acceptable pattern that can be sustained. Benefits exist even without weight loss, including prevention of further weight gain and improved general health. Avoid unvalidated supplements, restrictive diets and promises of cure. Assess and treat depression, anxiety, sleep symptoms and stigma because these can determine whether a plan is feasible.
For irregular bleeding when pregnancy is not desired, combined oral contraception can be considered for menstrual irregularity and hyperandrogenic symptoms after usual eligibility assessment. Regular progestogen exposure is important when cycles are infrequent, because long-standing untreated amenorrhoea increases endometrial hyperplasia risk. Progestin-only oral contraception may be considered for endometrial protection using general population guidance, although PCOS-specific evidence is limited. Investigate prolonged, heavy, intermenstrual or postcoital bleeding rather than assuming it is hormonal. Routine endometrial screening is not recommended in all PCOS; manage prolonged untreated amenorrhoea, higher weight, diabetes and persistent thickened endometrium as risk modifiers with gynaecology input.
For hirsutism, offer realistic cosmetic options such as laser or light therapy where suitable, and explain that hair response is slow. When pregnancy is wanted, establish ovulatory status and complete infertility assessment. Letrozole is first-line pharmacological ovulation induction for anovulatory infertility with no other infertility factors. Escalation to clomiphene with metformin, gonadotrophins, laparoscopic ovarian surgery or IVF belongs in a monitored fertility pathway because multifetal gestation and ovarian hyperstimulation risk must be managed.
Prescribing Information
Prescribing must follow pregnancy intention, contraindications, blood pressure, thrombosis risk, liver disease, renal function, current medicines and local formulary. Combined oral contraceptive pills (COCPs) can treat menstrual irregularity and hirsutism in adults with PCOS who do not wish to conceive. There is no evidence to endorse a single PCOS-specific formulation; use general contraceptive eligibility guidance and avoid treating a COCP as a substitute for metabolic screening. It can obscure biochemical androgen results, so interpret hormone testing with specialist advice when testing is essential.
Metformin should be considered in adults with PCOS and BMI at or above 25 kg/m2 for metabolic outcomes; it may be considered at lower BMI with limited evidence. Start and titrate only under a prescriber's plan, counsel about dose-related gastrointestinal effects and review renal function and vitamin B12 risk according to usual medicines guidance. Metformin is not a universal weight-loss drug, does not replace contraception and is not routinely continued in pregnancy solely because of PCOS. Inositol has limited clinical benefit compared with metformin, and product quality, dose and safety vary.
Anti-androgens are not first-line monotherapy. If hirsutism remains distressing after at least six months of COCP and/or cosmetic therapy, an anti-androgen may be considered only with effective contraception. Counsel explicitly that fetal exposure can impair development of external male genitalia; stop and seek specialist advice if pregnancy is suspected. The guideline notes lower adverse-effect risk with spironolactone at 25 to 100 mg/day, but this is not a self-treatment dose or a pregnancy-safe medicine. Finasteride, flutamide and bicalutamide have important toxicity concerns. Letrozole must not be given if an existing pregnancy is possible; ovulation induction requires pregnancy exclusion, cycle monitoring and a fertility plan.
When to Refer
Refer to gynaecology, endocrinology or a clinician experienced in PCOS when diagnosis is uncertain, symptoms are rapidly progressive, androgen levels are markedly raised, virilisation is present, amenorrhoea persists without a safe bleeding plan, abnormal uterine bleeding occurs, or a pelvic/adrenal tumour is possible. Refer urgently for severe headache or visual symptoms with galactorrhoea, suspected Cushing syndrome, or metabolic decompensation. Primary care should not wait for an ultrasound before escalating red-flag hyperandrogenism.
Seek fertility referral when pregnancy has not occurred after an appropriate interval for age and circumstances, earlier where there is amenorrhoea, known tubal disease, male factor, significant endometriosis or a concerning reproductive history. Fertility care should assess both partners where relevant and offer preconception diabetes testing, blood-pressure review, medication reconciliation, folate advice and mental-health support. Do not start ovulation medicines from an online plan or reuse a previous prescription.
Refer dietetic, psychology, dermatology, sleep or bariatric services according to need and availability, not as punishment for weight. Refer for diabetes, hypertension, dyslipidaemia, liver disease or sleep-apnoea evaluation when screening suggests disease. In India, service availability varies; document what was assessed, which treatment is possible locally, what needs specialist input and the return precautions while referral is pending.
Red Flags
Same-day assessment is required for heavy bleeding with dizziness, syncope, pregnancy possibility with pain or bleeding, severe pelvic pain, fever, a positive pregnancy test with unilateral pain, or symptoms of hyperglycaemia with dehydration. Sudden severe headache, visual loss, focal neurological deficit, chest pain, breathlessness or collapse must be treated as an emergency, not attributed to stress or PCOS.
Rapid virilisation, a new deep voice, clitoromegaly, rapidly advancing hirsutism, severe acne with systemic symptoms or a new abdominal mass requires urgent evaluation for an androgen-secreting tumour or another endocrine disorder. Persistent amenorrhoea with no hormonal/endometrial protection and abnormal bleeding after prolonged amenorrhoea need gynaecological review. Hirsutism itself is rarely an emergency; its rate of change is what matters.
Mental-health red flags include suicidal thoughts, self-harm, severe depression, coercion around weight or fertility, eating-disorder behaviours, or domestic violence. Ask directly and arrange crisis support using the local pathway. During fertility treatment, severe abdominal pain, rapid abdominal enlargement, vomiting, breathlessness, reduced urine output or sudden weight increase can indicate ovarian hyperstimulation and requires urgent contact with the treating fertility unit. PCOS does not protect against pregnancy complications: a pregnant person with headache, visual symptoms, upper-abdominal pain, breathlessness, bleeding or reduced fetal movement needs urgent maternity assessment.
Indian Clinical Context
Indian practice must avoid two opposite errors: treating PCOS as a cosmetic problem, and turning it into a blanket diagnosis for every irregular cycle. The international 2023 guideline supplies the evidence framework; its diagnostic cut-offs, medicine licensing and care pathways may not map exactly to every Indian setting. Verify local laboratory methods, product information, Medical Eligibility Criteria, state formulary and referral availability before prescribing. The guide makes no claim that a particular test, GLP-1 medicine, laser service, fertility procedure or specialist clinic is publicly funded or locally available.
Access barriers can include out-of-pocket testing, pressure to conceive soon after marriage, stigma about body hair or weight, food insecurity, limited safe spaces for exercise and fragmented care between dermatology, gynaecology and diabetes services. Use person-first language, ask what outcome matters now, and offer options rather than imposing a narrow ideal body size or diet. A culturally familiar pattern built around vegetables, pulses, protein, whole grains where feasible and less highly refined food can be discussed without claiming that any named Indian diet cures PCOS.
The appropriate response to a resource limitation is a transparent priority plan: exclude pregnancy and serious mimics, protect the endometrium where needed, obtain blood pressure and glycaemic assessment, address distress, and refer for concerning bleeding, virilisation or infertility. No supplement, herbal preparation or pharmacy combination should be presumed safe in pregnancy or compatible with prescribed contraception. Check all traditional and over-the-counter medicines non-judgementally.
NMC Competency Mapping
The NMC Competency Based Medical Education Curriculum 2024 is the educational foundation for undergraduate assessment, safe prescribing and referral in India. PCOS links reproductive endocrinology, menstrual disorders, infertility, dermatology, diabetes prevention, mental health, ethics and communication. This guide does not invent a condition-specific competency code; institutions should map teaching and assessment to the current approved obstetrics and gynaecology ledger.
At Know level, learners should explain the adult diagnostic framework, why adolescence needs different criteria, major mimics, cardiometabolic risk and the relation between chronic anovulation and endometrial protection. They should distinguish symptom control from fertility treatment and recognise that PCOS is associated with pregnancy and mental-health risk.
At Know How level, learners should obtain a sensitive menstrual, androgen, metabolic, medicine and pregnancy-intention history; measure blood pressure correctly; select initial exclusion tests; arrange glycaemic assessment; and identify which symptoms require urgent referral. They should counsel that COCPs, progestogen strategies, metformin, anti-androgens and ovulation induction have different purposes and pregnancy safeguards.
At Show How level, under supervision, learners should communicate without stigma, document shared decisions and contraception status, identify barriers to follow-up, prescribe only within competence and provide an accurate fertility or emergency referral. Assessment should reward diagnostic reasoning and safety-netting rather than memorisation of an ultrasound appearance or an unsupported drug regimen.
Key Exam Pearls for NEET PG
In adults, diagnose PCOS after excluding mimics when two of ovulatory dysfunction, hyperandrogenism and polycystic ovarian morphology or AMH are present. If irregular cycles and hyperandrogenism coexist, ultrasound or AMH is unnecessary. In adolescents, require both irregular cycles and hyperandrogenism; do not diagnose from ultrasound morphology or AMH. Remember that regular cycles do not always prove ovulation.
The 75-g OGTT is the most accurate glycaemic assessment in PCOS regardless of BMI; assess at diagnosis and repeat every one to three years according to risk. Do not use routine insulin assays to diagnose insulin resistance. Consider sleep-apnoea symptoms, depression and anxiety, blood pressure and lipids in the long-term plan.
For people not seeking pregnancy, COCPs can address irregular cycles and hirsutism after normal contraceptive eligibility assessment. Ensure endometrial protection in prolonged amenorrhoea. Metformin is primarily a metabolic medicine, not a universal infertility or cosmetic treatment. Anti-androgens require effective contraception because of fetal risk.
For anovulatory infertility with no other infertility factor, letrozole is first-line pharmacological ovulation induction; exclude pregnancy before treatment. Rapid virilisation suggests a tumour or another mimic, not ordinary PCOS. In a written answer, state diagnostic criteria, exclusions, metabolic screening, symptom-directed management, pregnancy intention and referral or safety-net plan.
Frequently Asked Questions
Does PCOS always mean that pregnancy will be difficult or impossible?
No. PCOS commonly causes anovulation, but many people conceive without fertility treatment and others respond to structured ovulation induction. The first step is to clarify whether ovulation is occurring and to assess other factors, including semen, tubal disease, age and timing. Do not delay review for years when cycles are very infrequent, but do not promise a pregnancy outcome from a diagnosis alone.
Why is diabetes testing recommended even when someone with PCOS is not overweight?
PCOS increases the risk of impaired glucose tolerance and type 2 diabetes across BMI categories. The 2023 guideline recommends glycaemic assessment at diagnosis and reassessment every one to three years based on individual risk. A 75-g oral glucose tolerance test is the most accurate test; fasting glucose or HbA1c may miss some dysglycaemia when an OGTT is not feasible.
How can irregular periods in PCOS affect the lining of the uterus?
Infrequent ovulation can mean prolonged unopposed oestrogen exposure, which increases endometrial hyperplasia risk. The absolute cancer risk remains low, so routine screening for everyone with PCOS is not recommended. The practical approach is to avoid prolonged untreated amenorrhoea, choose appropriate progestogen exposure when pregnancy is not desired, and investigate persistent, heavy or unusual bleeding rather than ignoring it.
Can spironolactone or fertility medicines be used if pregnancy is possible?
No medicine should be started without a pregnancy and contraception discussion. Anti-androgens can affect development of external male genitalia in a fetus and require reliable effective contraception. Letrozole is used for monitored ovulation induction but should not be given if a pre-existing pregnancy is possible. A clinician should set the testing, timing, monitoring and stop plan rather than relying on internet schedules.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic